Research Article

Clinical Evaluation of FOXO1 as a Tumor Suppressor in Prostate Cancer

Figure 4

Cell cycle in PCa cells promoted by the knockdown of FOXO1. In LNCaP (a) and PC-3 (b) cells, cells’ percentage in the G1 phase was decreased and that in the S phase was increased by the knockdown of FOXO1. Significance holds if is below 0.05 (; ; ).
(a)
(b)